Senior Director, Global Head FP&A

Senior Director, Global Head FP&A Summary

Cell Carta is a private‑equity backed life sciences services company that provides integrated laboratory and analytical platforms in immunology, histopathology, proteomics, and genomics to the biopharmaceutical industry. The Senior Director, Global Head FP&A will lead the global financial planning and analysis function, partnering with executive leadership and the private‑equity sponsor to drive financial reporting, forecasting, operational planning, and enterprise‑wide value creation for this leading CRO in the biomarker laboratory services segment.

• Own forecasting accuracy and monthly financial performance management
• Build and maintain reporting frameworks for backlog, bookings, revenue, costs, and cash flow
• Translate operational metrics into financial insights and predictive forecasts
• Lead scenario modeling related to demand volatility, staffing ramps, pricing changes, and regulatory impacts
• Establish consistent forecasting processes across regions and business units

• Lead long‑range planning, annual budget, and rolling forecast processes; work with divisional leaders to ensure visibility into demand, capacity, backlog, and performance
• Analyze key operational and financial drivers including resource and capacity utilization, standard costs and billable rates, contract mix, backlog to revenue conversion, and productivity
• Support M&A activities—acquisitions, add‑ons, and integrations—including financial modeling, diligence support, and synergy tracking

• Serve as primary FP&A interface with the private‑equity sponsor team
• Prepare board deck financials, KPI reporting, and other investor analyses
• Deliver insights on growth, profitability, and operational performance

• Lead and coach a high‑performing global FP&A team
• Drive standardization of reporting, planning tools, and data governance
• Partner with finance, IT, and operations to improve forecasting systems and business intelligence tools
• Optimize financial processes for scale, visibility, and transaction‑readiness

• Bachelor’s degree in Finance, Accounting, Economics, or related field (MBA, CPA, or CFA preferred)
• 10+ years of FP&A, corporate finance, consulting, or investment experience
• Experience in life sciences services (CRO, CDMO, diagnostics, or laboratory services) preferred
• Experience in private‑equity owned or highly growth‑oriented organizations strongly preferred
• Strong financial modeling and forecasting expertise
• Strong executive communication and presentation skills
• Willing to work Eastern Time Zone hours
• Experience working with global, cross‑functional teams

• Strong business acumen and judgement with knowledge of Cell Carta's market and services
• Expertise in services model economics and utilization‑based modeling
• Knowledge of U.S. GAAP accounting regulations and company accounting policies and practices
• Strong workload prioritization, resource management, and project management
• Highly analytical, detail‑oriented, and disciplined
• Ability to drive change and alignment across commercial, operations, and finance
• Comfortable operating in dynamic environments with evolving priorities
• Effective influencer and communicator

• Forecast accuracy and reliability
• EBITDA improvement driven through analytics and insights
• Utilization and margin optimization
• Quality and usefulness of board/investor reporting
• FP&A talent development and team scalability
• Readiness for acquisition, integration, and exit

• This position is 100% remote and can be based anywhere within the United States

• Competitive wages ($180,000 – $200,000 USD)
• Medical, dental, and vision benefits
• 401(k) retirement savings plan with a healthy match
• Vacation and sick time

Cell Carta supports the entire drug development cycle, from discovery to late‑stage clinical trials, by providing specialized precision medicine laboratory services. Leveraging its integrated analytical platforms in immunology,…